Prostate stem cell antigen polymorphism rs 2294008 and cancer risk : a meta-analysis

Xiaojie Ding,Haiyan Chu,Weidong Xu,Meilin Wang,Gaoxiang Ma,Zhengdong Zhang,Xiaoming,Luo
2016-01-01
Abstract:Prostate stem cell antigen (PSCA) is a cell surface protein, which has a cell-proliferation inhibition and/ or cell-death induction activity. Multiple studies have reported the association between PSCA rs2294008 polymorphism and cancer risk, which showed inconclusive results. This meta-analysis based on 39 studies involving 36,742 cases and 64,756 controls was performed to address this issue. We assessed the strength of the association, using odds ratios (ORs) with 95% confidence intervals (CIs). The statistical heterogeneity between studies was checked by χ2-based Q-test. Overall, the individuals with the TT/TC genotypes were associated with higher cancer risk than those with the CC genotype (TT/TC vs. CC: OR = 1.27, 95% CI = 1.17-1.39, Pheterogeneity < 0.001). In the stratified analyses, there was a significantly increased risk of gastric cancer (TT vs. CC: OR = 1.42, 95% CI = 1.16-1.73, Pheterogeneity < 0.001; TC vs. CC: 1.40, 1.27-1.55, Pheterogeneity < 0.001) and bladder cancer (TT vs. CC: 1.30, 1.22-1.39, Pheterogeneity = 0.417; TT vs. TC/CC: 1.14, 1.08-1.20, Pheterogeneity = 0.458) in all genetic models except recessive model. Moreover, significant effects were observed in both Asians and Caucasian populations (TT vs. CC: 1.21, 1.01-1.44, Pheterogeneity < 0.001; TT/TC vs. CC: 1.28, 1.14-1.43, Pheterogeneity < 0.001 for Asians and TT vs. CC: 1.46, 1.23-1.74, Pheterogeneity < 0.001; TT/TC vs. CC: 1.25, 1.09-1.44, Pheterogeneity < 0.001 for Caucasians). These findings supported that PSCA rs2294008 polymorphism may contribute to the susceptibility of cancers, especially among gastric cancer and bladder cancer.
What problem does this paper attempt to address?